Bifogade filer
260421 Mentice AR25 EN
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Mentice AB (publ), Gothenburg – a globally recognized leader in simulation solutions for image-guided therapies, today published its Annual Report and Sustainability Report for 2025.
The year concluded with a strong finish and improved profitability, marking an important step in Mentice transition towards scalable growth. In the first half of the year Mentice faced wavering demand due to the macroeconomic environment, however the business proved resilient and the second half of the year reflects the continued investments and efforts made to strengthen fundamentals, increase operational efficiency, and grow demand.
Net sales for the year totaled SEK 279.1 million and were 3.9% lower than the previous year. Adjusted for currency effects, organic growth reached 3.4%. Order intake increased 2.2% to SEK 285.1 million, with 7.9% organic growth. EBITDA in the fourth quarter reached SEK 23 million, resulting in full-year EBITDA of SEK 3.4 million, despite significant impact from low market activity in the first quarter and the costs associated with the organizational realignment in the second quarter.
CEO, Frans Venker comments:
“2025 has been a year of transition, where we have deliberately invested in our future growth while navigating a more cautious market environment compared to 2024,” says Frans Venker, CEO of Mentice AB. “At the same time, we are seeing clear signs of strengthening demand and improved profitability as we exit the year.
Our position as a trusted partner to leading MedTech companies continues to strengthen, supported by a growing pipeline and deeper customer collaborations. As we move into 2026, we do so with increasing confidence, focused on accelerating growth, particularly in the U.S., while continuing to expand our market leading offering and drive innovation at the intersection of simulation, customer focus and ultimately patient outcomes.”
The Annual Report 2025 provides a comprehensive overview of Mentice operational and financial performance, market developments, strategic priorities, and sustainability initiatives. It is available to shareholders and interested parties at: https://investor.mentice.com/financial-report/2025.
A printed copy can be requested in writing by contacting: alexandra.deising@mentice.com.